According to the source, the Union government has allowed the commercial export of both vaccines - Covishield and Covaxin - in view of sufficient stock of the vaccines available with the states and Union Territories, and also with the manufacturers.
An MoU was signed to recognise Covid-19 vaccine certification by India's Ambassador to Nepal Vinay Mohan Kwatra and the Himalayan nation's Health Secretary on Tuesday.
Of eight WHO-approved vaccines against Covid-19 in emergency use listing, two vaccines -- Covaxin and Covishield -- are from India.
Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.
Five more countries on Monday recognised India's vaccine certificate, after Australia recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine
The top court told the petitioner's counsel that it finds no error with the high court decision in the matter, and it will not entertain the petition.
There is no difference in antibodies produced by Covaxin and Covishield vaccines against the Covid-19 virus. This information was shared by Odisha Health Services Director Bijay Mohapatra on Monday (Sept 27).
We are engaging with the Government of India to explore how we could expand UK recognition of vaccine certification to people vaccinated by a relevant public health body in India, said a British High Commission spokesperson.
Stating that there is no shortage of vaccines in the country, the source said that the Centre is capable of supplying as many vaccine doses the states need, in real-time without any delay.
The government in May had further extended the gap between the two doses of Covishield from 6-8 weeks to 12-16 weeks and said the decision to increase the gap was based on scientific evidence.
As per a BBC report, the World Health Organisation (WHO) has identified counterfeit versions of India's primary Covid vaccine, Covishield
These findings have an important implication for the COVID-19 vaccination program wherein heterologous immunisation will pave the way for induction of improved and better protection against the variant strains of SARS-CoV-2.
The Department of Biotechnology under the Ministry of Science and Technology has launched 'Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission'.
"If an Indian citizen beneficiary has taken first dose of Covishield or AstraZeneca (ChAdOx1 nCov-19) vaccine outside India, the beneficiary can register on CoWIN app at the time of taking the second dose of Covishield vaccine after prescribed time interval and details of first dose can be recorded on the CoWIN app at the same time."
The State Health Department of Odisha has requested the Centre to allocate the balance Covid vaccine doses under private hospitals share to the State government.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.